img

Global Drug Phenotypic Screening Platform Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Drug Phenotypic Screening Platform Market Research Report 2024

According to MRAResearch’s new survey, global Drug Phenotypic Screening Platform market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033.
Key companies engaged in the Drug Phenotypic Screening Platform industry include Melior Discovery, Creative Biolabs, PerkinElmer, TargetMol, MIMETAS, Evotec, ThermoScientific, Eurofins Discovery and Horizon Discovery, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Drug Phenotypic Screening Platform were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Drug Phenotypic Screening Platform market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Drug Phenotypic Screening Platform market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Melior Discovery
Creative Biolabs
PerkinElmer
TargetMol
MIMETAS
Evotec
ThermoScientific
Eurofins Discovery
Horizon Discovery
Crown Bioscience
Pharmaron
HD Biosciences
Segment by Type
In Vivo Screening
In Vitro Screening

Segment by Application


Pharmaceutical Company
Research Institute
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Drug Phenotypic Screening Platform report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Phenotypic Screening Platform Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 In Vivo Screening
1.2.3 In Vitro Screening
1.3 Market by Application
1.3.1 Global Drug Phenotypic Screening Platform Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Pharmaceutical Company
1.3.3 Research Institute
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Phenotypic Screening Platform Market Perspective (2018-2033)
2.2 Drug Phenotypic Screening Platform Growth Trends by Region
2.2.1 Global Drug Phenotypic Screening Platform Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Drug Phenotypic Screening Platform Historic Market Size by Region (2018-2023)
2.2.3 Drug Phenotypic Screening Platform Forecasted Market Size by Region (2024-2033)
2.3 Drug Phenotypic Screening Platform Market Dynamics
2.3.1 Drug Phenotypic Screening Platform Industry Trends
2.3.2 Drug Phenotypic Screening Platform Market Drivers
2.3.3 Drug Phenotypic Screening Platform Market Challenges
2.3.4 Drug Phenotypic Screening Platform Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Phenotypic Screening Platform Players by Revenue
3.1.1 Global Top Drug Phenotypic Screening Platform Players by Revenue (2018-2023)
3.1.2 Global Drug Phenotypic Screening Platform Revenue Market Share by Players (2018-2023)
3.2 Global Drug Phenotypic Screening Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug Phenotypic Screening Platform Revenue
3.4 Global Drug Phenotypic Screening Platform Market Concentration Ratio
3.4.1 Global Drug Phenotypic Screening Platform Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Phenotypic Screening Platform Revenue in 2022
3.5 Drug Phenotypic Screening Platform Key Players Head office and Area Served
3.6 Key Players Drug Phenotypic Screening Platform Product Solution and Service
3.7 Date of Enter into Drug Phenotypic Screening Platform Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Phenotypic Screening Platform Breakdown Data by Type
4.1 Global Drug Phenotypic Screening Platform Historic Market Size by Type (2018-2023)
4.2 Global Drug Phenotypic Screening Platform Forecasted Market Size by Type (2024-2033)
5 Drug Phenotypic Screening Platform Breakdown Data by Application
5.1 Global Drug Phenotypic Screening Platform Historic Market Size by Application (2018-2023)
5.2 Global Drug Phenotypic Screening Platform Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Drug Phenotypic Screening Platform Market Size (2018-2033)
6.2 North America Drug Phenotypic Screening Platform Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Drug Phenotypic Screening Platform Market Size by Country (2018-2023)
6.4 North America Drug Phenotypic Screening Platform Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Phenotypic Screening Platform Market Size (2018-2033)
7.2 Europe Drug Phenotypic Screening Platform Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Drug Phenotypic Screening Platform Market Size by Country (2018-2023)
7.4 Europe Drug Phenotypic Screening Platform Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Phenotypic Screening Platform Market Size (2018-2033)
8.2 Asia-Pacific Drug Phenotypic Screening Platform Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Drug Phenotypic Screening Platform Market Size by Region (2018-2023)
8.4 Asia-Pacific Drug Phenotypic Screening Platform Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Phenotypic Screening Platform Market Size (2018-2033)
9.2 Latin America Drug Phenotypic Screening Platform Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Drug Phenotypic Screening Platform Market Size by Country (2018-2023)
9.4 Latin America Drug Phenotypic Screening Platform Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Phenotypic Screening Platform Market Size (2018-2033)
10.2 Middle East & Africa Drug Phenotypic Screening Platform Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Drug Phenotypic Screening Platform Market Size by Country (2018-2023)
10.4 Middle East & Africa Drug Phenotypic Screening Platform Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Melior Discovery
11.1.1 Melior Discovery Company Detail
11.1.2 Melior Discovery Business Overview
11.1.3 Melior Discovery Drug Phenotypic Screening Platform Introduction
11.1.4 Melior Discovery Revenue in Drug Phenotypic Screening Platform Business (2018-2023)
11.1.5 Melior Discovery Recent Development
11.2 Creative Biolabs
11.2.1 Creative Biolabs Company Detail
11.2.2 Creative Biolabs Business Overview
11.2.3 Creative Biolabs Drug Phenotypic Screening Platform Introduction
11.2.4 Creative Biolabs Revenue in Drug Phenotypic Screening Platform Business (2018-2023)
11.2.5 Creative Biolabs Recent Development
11.3 PerkinElmer
11.3.1 PerkinElmer Company Detail
11.3.2 PerkinElmer Business Overview
11.3.3 PerkinElmer Drug Phenotypic Screening Platform Introduction
11.3.4 PerkinElmer Revenue in Drug Phenotypic Screening Platform Business (2018-2023)
11.3.5 PerkinElmer Recent Development
11.4 TargetMol
11.4.1 TargetMol Company Detail
11.4.2 TargetMol Business Overview
11.4.3 TargetMol Drug Phenotypic Screening Platform Introduction
11.4.4 TargetMol Revenue in Drug Phenotypic Screening Platform Business (2018-2023)
11.4.5 TargetMol Recent Development
11.5 MIMETAS
11.5.1 MIMETAS Company Detail
11.5.2 MIMETAS Business Overview
11.5.3 MIMETAS Drug Phenotypic Screening Platform Introduction
11.5.4 MIMETAS Revenue in Drug Phenotypic Screening Platform Business (2018-2023)
11.5.5 MIMETAS Recent Development
11.6 Evotec
11.6.1 Evotec Company Detail
11.6.2 Evotec Business Overview
11.6.3 Evotec Drug Phenotypic Screening Platform Introduction
11.6.4 Evotec Revenue in Drug Phenotypic Screening Platform Business (2018-2023)
11.6.5 Evotec Recent Development
11.7 ThermoScientific
11.7.1 ThermoScientific Company Detail
11.7.2 ThermoScientific Business Overview
11.7.3 ThermoScientific Drug Phenotypic Screening Platform Introduction
11.7.4 ThermoScientific Revenue in Drug Phenotypic Screening Platform Business (2018-2023)
11.7.5 ThermoScientific Recent Development
11.8 Eurofins Discovery
11.8.1 Eurofins Discovery Company Detail
11.8.2 Eurofins Discovery Business Overview
11.8.3 Eurofins Discovery Drug Phenotypic Screening Platform Introduction
11.8.4 Eurofins Discovery Revenue in Drug Phenotypic Screening Platform Business (2018-2023)
11.8.5 Eurofins Discovery Recent Development
11.9 Horizon Discovery
11.9.1 Horizon Discovery Company Detail
11.9.2 Horizon Discovery Business Overview
11.9.3 Horizon Discovery Drug Phenotypic Screening Platform Introduction
11.9.4 Horizon Discovery Revenue in Drug Phenotypic Screening Platform Business (2018-2023)
11.9.5 Horizon Discovery Recent Development
11.10 Crown Bioscience
11.10.1 Crown Bioscience Company Detail
11.10.2 Crown Bioscience Business Overview
11.10.3 Crown Bioscience Drug Phenotypic Screening Platform Introduction
11.10.4 Crown Bioscience Revenue in Drug Phenotypic Screening Platform Business (2018-2023)
11.10.5 Crown Bioscience Recent Development
11.11 Pharmaron
11.11.1 Pharmaron Company Detail
11.11.2 Pharmaron Business Overview
11.11.3 Pharmaron Drug Phenotypic Screening Platform Introduction
11.11.4 Pharmaron Revenue in Drug Phenotypic Screening Platform Business (2018-2023)
11.11.5 Pharmaron Recent Development
11.12 HD Biosciences
11.12.1 HD Biosciences Company Detail
11.12.2 HD Biosciences Business Overview
11.12.3 HD Biosciences Drug Phenotypic Screening Platform Introduction
11.12.4 HD Biosciences Revenue in Drug Phenotypic Screening Platform Business (2018-2023)
11.12.5 HD Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Drug Phenotypic Screening Platform Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of In Vivo Screening
Table 3. Key Players of In Vitro Screening
Table 4. Global Drug Phenotypic Screening Platform Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Drug Phenotypic Screening Platform Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Drug Phenotypic Screening Platform Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Drug Phenotypic Screening Platform Market Share by Region (2018-2023)
Table 8. Global Drug Phenotypic Screening Platform Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Drug Phenotypic Screening Platform Market Share by Region (2024-2033)
Table 10. Drug Phenotypic Screening Platform Market Trends
Table 11. Drug Phenotypic Screening Platform Market Drivers
Table 12. Drug Phenotypic Screening Platform Market Challenges
Table 13. Drug Phenotypic Screening Platform Market Restraints
Table 14. Global Drug Phenotypic Screening Platform Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Drug Phenotypic Screening Platform Market Share by Players (2018-2023)
Table 16. Global Top Drug Phenotypic Screening Platform Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Phenotypic Screening Platform as of 2022)
Table 17. Ranking of Global Top Drug Phenotypic Screening Platform Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Drug Phenotypic Screening Platform Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Drug Phenotypic Screening Platform Product Solution and Service
Table 21. Date of Enter into Drug Phenotypic Screening Platform Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Drug Phenotypic Screening Platform Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Drug Phenotypic Screening Platform Revenue Market Share by Type (2018-2023)
Table 25. Global Drug Phenotypic Screening Platform Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Drug Phenotypic Screening Platform Revenue Market Share by Type (2024-2033)
Table 27. Global Drug Phenotypic Screening Platform Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Drug Phenotypic Screening Platform Revenue Market Share by Application (2018-2023)
Table 29. Global Drug Phenotypic Screening Platform Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Drug Phenotypic Screening Platform Revenue Market Share by Application (2024-2033)
Table 31. North America Drug Phenotypic Screening Platform Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Drug Phenotypic Screening Platform Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Drug Phenotypic Screening Platform Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Drug Phenotypic Screening Platform Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Drug Phenotypic Screening Platform Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Drug Phenotypic Screening Platform Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Drug Phenotypic Screening Platform Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Drug Phenotypic Screening Platform Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Drug Phenotypic Screening Platform Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Drug Phenotypic Screening Platform Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Drug Phenotypic Screening Platform Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Drug Phenotypic Screening Platform Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Drug Phenotypic Screening Platform Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Drug Phenotypic Screening Platform Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Drug Phenotypic Screening Platform Market Size by Country (2024-2033) & (US$ Million)
Table 46. Melior Discovery Company Detail
Table 47. Melior Discovery Business Overview
Table 48. Melior Discovery Drug Phenotypic Screening Platform Product
Table 49. Melior Discovery Revenue in Drug Phenotypic Screening Platform Business (2018-2023) & (US$ Million)
Table 50. Melior Discovery Recent Development
Table 51. Creative Biolabs Company Detail
Table 52. Creative Biolabs Business Overview
Table 53. Creative Biolabs Drug Phenotypic Screening Platform Product
Table 54. Creative Biolabs Revenue in Drug Phenotypic Screening Platform Business (2018-2023) & (US$ Million)
Table 55. Creative Biolabs Recent Development
Table 56. PerkinElmer Company Detail
Table 57. PerkinElmer Business Overview
Table 58. PerkinElmer Drug Phenotypic Screening Platform Product
Table 59. PerkinElmer Revenue in Drug Phenotypic Screening Platform Business (2018-2023) & (US$ Million)
Table 60. PerkinElmer Recent Development
Table 61. TargetMol Company Detail
Table 62. TargetMol Business Overview
Table 63. TargetMol Drug Phenotypic Screening Platform Product
Table 64. TargetMol Revenue in Drug Phenotypic Screening Platform Business (2018-2023) & (US$ Million)
Table 65. TargetMol Recent Development
Table 66. MIMETAS Company Detail
Table 67. MIMETAS Business Overview
Table 68. MIMETAS Drug Phenotypic Screening Platform Product
Table 69. MIMETAS Revenue in Drug Phenotypic Screening Platform Business (2018-2023) & (US$ Million)
Table 70. MIMETAS Recent Development
Table 71. Evotec Company Detail
Table 72. Evotec Business Overview
Table 73. Evotec Drug Phenotypic Screening Platform Product
Table 74. Evotec Revenue in Drug Phenotypic Screening Platform Business (2018-2023) & (US$ Million)
Table 75. Evotec Recent Development
Table 76. ThermoScientific Company Detail
Table 77. ThermoScientific Business Overview
Table 78. ThermoScientific Drug Phenotypic Screening Platform Product
Table 79. ThermoScientific Revenue in Drug Phenotypic Screening Platform Business (2018-2023) & (US$ Million)
Table 80. ThermoScientific Recent Development
Table 81. Eurofins Discovery Company Detail
Table 82. Eurofins Discovery Business Overview
Table 83. Eurofins Discovery Drug Phenotypic Screening Platform Product
Table 84. Eurofins Discovery Revenue in Drug Phenotypic Screening Platform Business (2018-2023) & (US$ Million)
Table 85. Eurofins Discovery Recent Development
Table 86. Horizon Discovery Company Detail
Table 87. Horizon Discovery Business Overview
Table 88. Horizon Discovery Drug Phenotypic Screening Platform Product
Table 89. Horizon Discovery Revenue in Drug Phenotypic Screening Platform Business (2018-2023) & (US$ Million)
Table 90. Horizon Discovery Recent Development
Table 91. Crown Bioscience Company Detail
Table 92. Crown Bioscience Business Overview
Table 93. Crown Bioscience Drug Phenotypic Screening Platform Product
Table 94. Crown Bioscience Revenue in Drug Phenotypic Screening Platform Business (2018-2023) & (US$ Million)
Table 95. Crown Bioscience Recent Development
Table 96. Pharmaron Company Detail
Table 97. Pharmaron Business Overview
Table 98. Pharmaron Drug Phenotypic Screening Platform Product
Table 99. Pharmaron Revenue in Drug Phenotypic Screening Platform Business (2018-2023) & (US$ Million)
Table 100. Pharmaron Recent Development
Table 101. HD Biosciences Company Detail
Table 102. HD Biosciences Business Overview
Table 103. HD Biosciences Drug Phenotypic Screening Platform Product
Table 104. HD Biosciences Revenue in Drug Phenotypic Screening Platform Business (2018-2023) & (US$ Million)
Table 105. HD Biosciences Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drug Phenotypic Screening Platform Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Drug Phenotypic Screening Platform Market Share by Type: 2022 VS 2033
Figure 3. In Vivo Screening Features
Figure 4. In Vitro Screening Features
Figure 5. Global Drug Phenotypic Screening Platform Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Drug Phenotypic Screening Platform Market Share by Application: 2022 VS 2033
Figure 7. Pharmaceutical Company Case Studies
Figure 8. Research Institute Case Studies
Figure 9. Others Case Studies
Figure 10. Drug Phenotypic Screening Platform Report Years Considered
Figure 11. Global Drug Phenotypic Screening Platform Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Drug Phenotypic Screening Platform Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Drug Phenotypic Screening Platform Market Share by Region: 2022 VS 2033
Figure 14. Global Drug Phenotypic Screening Platform Market Share by Players in 2022
Figure 15. Global Top Drug Phenotypic Screening Platform Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Phenotypic Screening Platform as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Drug Phenotypic Screening Platform Revenue in 2022
Figure 17. North America Drug Phenotypic Screening Platform Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Drug Phenotypic Screening Platform Market Share by Country (2018-2033)
Figure 19. United States Drug Phenotypic Screening Platform Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Drug Phenotypic Screening Platform Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Drug Phenotypic Screening Platform Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Drug Phenotypic Screening Platform Market Share by Country (2018-2033)
Figure 23. Germany Drug Phenotypic Screening Platform Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Drug Phenotypic Screening Platform Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Drug Phenotypic Screening Platform Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Drug Phenotypic Screening Platform Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Drug Phenotypic Screening Platform Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Drug Phenotypic Screening Platform Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Drug Phenotypic Screening Platform Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Drug Phenotypic Screening Platform Market Share by Region (2018-2033)
Figure 31. China Drug Phenotypic Screening Platform Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Drug Phenotypic Screening Platform Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Drug Phenotypic Screening Platform Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Drug Phenotypic Screening Platform Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Drug Phenotypic Screening Platform Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Drug Phenotypic Screening Platform Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Drug Phenotypic Screening Platform Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Drug Phenotypic Screening Platform Market Share by Country (2018-2033)
Figure 39. Mexico Drug Phenotypic Screening Platform Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Drug Phenotypic Screening Platform Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Drug Phenotypic Screening Platform Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Drug Phenotypic Screening Platform Market Share by Country (2018-2033)
Figure 43. Turkey Drug Phenotypic Screening Platform Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Drug Phenotypic Screening Platform Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Melior Discovery Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2018-2023)
Figure 46. Creative Biolabs Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2018-2023)
Figure 47. PerkinElmer Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2018-2023)
Figure 48. TargetMol Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2018-2023)
Figure 49. MIMETAS Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2018-2023)
Figure 50. Evotec Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2018-2023)
Figure 51. ThermoScientific Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2018-2023)
Figure 52. Eurofins Discovery Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2018-2023)
Figure 53. Horizon Discovery Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2018-2023)
Figure 54. Crown Bioscience Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2018-2023)
Figure 55. Pharmaron Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2018-2023)
Figure 56. HD Biosciences Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed